JP2022546384A5 - - Google Patents
Info
- Publication number
- JP2022546384A5 JP2022546384A5 JP2022512869A JP2022512869A JP2022546384A5 JP 2022546384 A5 JP2022546384 A5 JP 2022546384A5 JP 2022512869 A JP2022512869 A JP 2022512869A JP 2022512869 A JP2022512869 A JP 2022512869A JP 2022546384 A5 JP2022546384 A5 JP 2022546384A5
- Authority
- JP
- Japan
- Prior art keywords
- gly
- cancer
- val
- sequence
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962890936P | 2019-08-23 | 2019-08-23 | |
| US62/890,936 | 2019-08-23 | ||
| PCT/US2020/040230 WO2021040881A1 (en) | 2019-08-23 | 2020-06-30 | Immune tolerant elastin-like recombinant peptides and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546384A JP2022546384A (ja) | 2022-11-04 |
| JP2022546384A5 true JP2022546384A5 (enExample) | 2023-07-07 |
Family
ID=74683687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512869A Ceased JP2022546384A (ja) | 2019-08-23 | 2020-06-30 | 免疫耐性エラスチン様組換ペプチドおよび使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220280615A1 (enExample) |
| EP (1) | EP4017541A4 (enExample) |
| JP (1) | JP2022546384A (enExample) |
| KR (1) | KR20220103916A (enExample) |
| CN (1) | CN114667160A (enExample) |
| BR (1) | BR112022003498A2 (enExample) |
| CA (1) | CA3149274A1 (enExample) |
| IL (1) | IL290839A (enExample) |
| MX (1) | MX2022002293A (enExample) |
| WO (1) | WO2021040881A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113444182B (zh) * | 2021-06-22 | 2022-07-19 | 四川大学华西医院 | 一种靶向递送IgG类抗体的融合蛋白载体及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006110292A2 (en) * | 2005-03-25 | 2006-10-19 | The Regents Of The University Of California | Temperature-triggered immobilization and purification of antibodies |
| JP2014529997A (ja) * | 2011-09-23 | 2014-11-17 | ウニヴェルズィテート シュトゥットガルト | 免疫グロブリン結合ドメインを使った血清中半減期延長 |
| JP6924151B2 (ja) * | 2015-05-29 | 2021-08-25 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | 免疫寛容及び非免疫寛容エラスチン様組換えペプチドならびに使用方法 |
| EP3691693A4 (en) * | 2017-10-06 | 2021-08-25 | University Of Utah Research Foundation | FUSION PROTEIN FOR TARGETED THERAPY OF AUTOIMMUNE DISEASE |
| WO2019144309A1 (en) * | 2018-01-24 | 2019-08-01 | Beijing Percans Oncology Co. Ltd. | Cytokine Fusion Proteins |
-
2020
- 2020-06-30 MX MX2022002293A patent/MX2022002293A/es unknown
- 2020-06-30 EP EP20856151.4A patent/EP4017541A4/en not_active Withdrawn
- 2020-06-30 WO PCT/US2020/040230 patent/WO2021040881A1/en not_active Ceased
- 2020-06-30 JP JP2022512869A patent/JP2022546384A/ja not_active Ceased
- 2020-06-30 US US17/637,639 patent/US20220280615A1/en not_active Abandoned
- 2020-06-30 CA CA3149274A patent/CA3149274A1/en active Pending
- 2020-06-30 KR KR1020227009130A patent/KR20220103916A/ko not_active Ceased
- 2020-06-30 CN CN202080074005.2A patent/CN114667160A/zh active Pending
- 2020-06-30 BR BR112022003498A patent/BR112022003498A2/pt unknown
-
2022
- 2022-02-23 IL IL290839A patent/IL290839A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024099850A5 (enExample) | ||
| JP2021120406A5 (ja) | 癌を治療するための組み合わせ物 | |
| JP2021058197A5 (enExample) | ||
| RU2012121875A (ru) | Антитела, распознающие содержащий углеводы эпитоп на cd-43 и сеа, экспрессируемых на злокачественных клетках, и способы их применения | |
| JP2019520426A5 (enExample) | ||
| RU2013155455A (ru) | Антитела для лечения раковых заболеваний, при которых эскспрессируется клаудин 6 | |
| JP2010531140A5 (enExample) | ||
| JP2020501531A5 (enExample) | ||
| CA2595610A1 (en) | Antibodies directed to angiopoietin-2 and uses thereof | |
| RU2012137503A (ru) | Лекарственный препарат для лечения и/или профилактики рака | |
| JPWO2020027100A5 (enExample) | ||
| CN110740754A (zh) | 一种抗间皮素抗体及其抗体药物缀合物 | |
| RU2016150377A (ru) | Сайт-специфичная конъюгация линкерных лекарственных препаратов с антителами и получаемые в результате adc | |
| JP2017506217A5 (enExample) | ||
| RU2018100424A (ru) | Комбинированная терапия для лечения злокачественной опухоли | |
| JP2020522474A5 (enExample) | ||
| JP2016514103A5 (ja) | 細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体 | |
| RU2018104266A (ru) | Полилигандные лекарственные конъюгаты и их применения | |
| JP2012196206A5 (enExample) | ||
| JP2010535713A5 (enExample) | ||
| JP2022169589A5 (enExample) | ||
| JP2014502955A5 (enExample) | ||
| KR101993963B1 (ko) | 항 종양제 및 항 종양 효과 증강제 | |
| RU2019111303A (ru) | Антитела против edb и конъюгаты антитело-лекарственное средство | |
| RU2018107693A (ru) | Комбинированные виды лечения и их варианты применения и способы |